Prediction of Treatment Efficacy and Telaprevir-Resistant Variants After Triple Therapy in Patients Infected With Hepatitis C Virus Genotype 1

Journal of Clinical Microbiology - United States
doi 10.1128/jcm.01129-13

Related search